2 not yet recruiting, 1 completed, 1 recruiting. 2 Not applicable, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Not yet recruiting 2 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Antipsychotic Induced Weight Gain: new trials by email Literature Review of Antipsychotic Induced Weight Gain trials Research Report on Antipsychotic Induced Weight Gain
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Relation Between Craving Induction and Treatment Response in Deep Transcranial Magnetic Stimulation (dTMS) for Reducing Antipsychotic-induced Weight Gain in Schizophrenia Deep Transcranial Magnetic Stimulation (dTMS) H4 coil - Active, Deep Transcranial Magnetic Stimulation (dTMS) H4 coil - Sham - Schizophrenia, Antipsychotic Induced Weight Gain | Not applicable | Not yet recruiting | Second Xiangya Hospital of Central South University | 30 | 2026-09-01 | 2026-09-08 |
| The Safety and Effectiveness of dTMS for Reducing Antipsychotic-induced Weight Gain dTMS of accelerated intermittent theta burst stimulation, ACC-iTBS, Sham stimulation - Schizophrenia Spectrum, Schizophrenia | Not applicable | Not yet recruiting | Second Xiangya Hospital of Central South University | 60 | 2026-09-01 | 2026-09-04 |
| : EFFECT OF PROBIOTIC SUPPLEMENTATION ON ATYPICAL ANTIPSYCHOTIC INDUCED WEIGHT GAIN IN PATIENTS ATTENDING PSYCHIATRIC CLINICS AT AINSHAMS UNIVERSITY HOSPITALS (A RANDOMIZED CONTROLLED TRIAL) lactobacillus LS - Antipsychotic Induced Weight Gain | Phase 3 | Recruiting | Ain Shams University | 180 | 2025-04-20 | 2025-04-20 |
| Study to Evaluate the Effects of a Cytochrome P450 2C19 Inhibitor on the Pharmacokinetics of Miricorilant Miricorilant, Fluvoxamine - Antipsychotic Induced Weight Gain, Non-alcoholic Steatohepatitis (NASH) | Phase 1 | Completed | Corcept Therapeutics | 26 | 2023-01-24 | 2023-03-22 |
Schizophrenia (2) · Non-alcoholic Fatty Liver Disease (1)
Mental Disorders (2) · Schizophrenia Spectrum and Other Psychotic Disorders (2) · Digestive System Diseases (1) · Fatty Liver (1) · Liver Diseases (1)
CORT118335 (1) · Fluvoxamine (1) · Lacteol (1)
Second Xiangya Hospital of Central South University (2) · Ain Shams University (1) · Corcept Therapeutics (1)
China (2) · Egypt (1) · United States (1)